World Health Organisation (WHO) survey on SARS-COV-2 Ag-RDTs
Thank you for taking the time to assist the World Health Organization (WHO) with generating a global understanding of current policy and experiences with SARS-COV-2 antigen rapid diagnostic tests (SARS-COV-2 Ag-RDTs) for both professional testing (i.e. tests performed and interpreted by a trained provider) and for self-testing (e.g. tests performed and interpreted by an individual, including untrained users, often at home or other locations).
This survey will take less than 15 minutes. All questions in this survey focus on SARS-COV-2 Ag-RDTs. When referring to the use of SARS-COV-2 Ag-RDTs for self-testing the term SARS-COV-2 self-tests may be used. Responses will be utilized as a part of WHO’s guideline development process. We will acknowledge your specific contribution in any publications that result from using your data.
At the end of the questionnaire, we request you to share reference materials, such as policy documents, programme data, and information on research activities. For documents available online we will ask you to share the website and URL links. You may also consider pre-assembling materials and providing us a link for accessing materials (e.g. Wetransfer, Dropbox, Google Drive, One Drive) and/or emailing act-tb@kuhes.ac.mw.
You do not need to complete the survey in one session and you may save and resume later. If electronic completion is not feasible or you run into any technical difficulties please contact act-tb@kuhes.ac.mw.